Market News & Trends
Sagent Pharmaceuticals Acquires Product Portfolio
Sagent Pharmaceuticals, Inc. recently announced it has entered into a definitive agreement with Teva Pharmaceutical Industries Ltd. (Teva) and Actavis LLC to acquire a portfolio…
Crown Bioscience Announces Strengthening of Global Immuno-Oncology Platform
Crown Bioscience recently announced the strengthening of its global Immuno-Oncology Platform at all its key facilities in Europe, US, and Asia to support client’s needs…
Argos Therapeutics Enters Strategic Research Agreement With Adaptive Biotechnologies
Argos Therapeutics, Inc. recently announced that it is partnering with Adaptive Biotechnologies Corporation, based in Seattle, WA, to study precise response patterns to Argos’ investigational…
Aegerion Pharmaceuticals & QLT Agree to Strategic Merger
Aegerion Pharmaceuticals, Inc. and QLT Inc. recently announced they have entered into a definitive merger agreement under which Aegerion will be merged with a wholly…
Pharmaceutical Industry Licensing Deals Soared to Record $46.2 Billion in 2015
Licensing deal values in the pharmaceutical industry rose by 37.1% year-to-year, from $33.7 billion in 2014 to $46.2 billion in 2015, driven primarily by Sanofi,…
Pharmaceutical Industry Licensing Deals Soared to Record $46.2 Billion in 2015
Licensing deal values in the pharmaceutical industry rose by 37.1% year-to-year, from $33.7 billion in 2014 to $46.2 billion in 2015, driven primarily by Sanofi,…
Ultragenyx & Takeda Enter Development & Commercialization Collaboration
Ultragenyx Pharmaceutical Inc. and Takeda Pharmaceutical Company Limited recently announced a strategic partnership to develop and commercialize therapies to treat rare genetic diseases. Ultragenyx will…
Enable Injections Completes Cincinnati Manufacturing Facility for On-Body Delivery Systems
Enable Injections Inc. opened its new Cincinnati manufacturing facility this month, the company announced at the BIO meeting in San Francisco. Enable Injections’ advanced On…
Cobra Biologics & Touchlight Collaborate on Production of Next-Generation DNA Constructs
Cobra Biologics Ltd and Touchlight are collaborating on a project to optimize the manufacture of Adeno-Associated Virus (AAV) vectors used in the delivery of gene…
BioDuro Launches as Unique Contract Research & Drug Manufacturing Organization
BioDuro, LLC recently announced the formal launch of the BioDuro organization, having merged with Formex to become an end-to-end solution provider for integrated drug discovery…
Averica & Dalton Announce Analytical Chemistry Services Agreement
Averica Discovery Services Inc. and Dalton Pharma Services recently announced a preferred provider agreement involving advanced analytical services. The agreement leverages the strengths of both…
Pharmaceutical Companies Increasingly Looking to Innovate High-Risk, First-In-Class Products
With the cost of bringing a single novel drug to market estimated to be $2.6 billion in 2015, pharmaceutical companies are increasingly looking towards developing…
PYRAMID Laboratories Celebrates 28th Anniversary; Expands Capabilities
PYRAMID Laboratories, Inc. a premier clinical and commercial contract aseptic drug product developer and manufacturer is proud to announce it is celebrating 28 years of…
Is Your Plastic Material Suitable for Pharmaceutical Use?
If you are considering registering plastic material with the FDA in a Drug Master File (DMF), evaluating the safety of that plastic is…
West Introduces 1- to 3-mL NovaPure® Plunger for Higher Volume Injections
West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, recently announced the availability of the 1- to 3-mL NovaPure® plunger…
Phillips-Medsize Acquires Medicom
Phillips-Medisize Corporation recently announced that it has acquired Medicom Innovation Partner, a leading provider of device strategy, product design, and development services with particular focus…
Genisphere Signs Collaborative Research, Option to License Agreement With MedImmune
Genisphere LLC recently announced it has executed a collaborative research and option to license agreement with MedImmune, the global biologics research and development arm of…
Noxilizer Announces FDA 510(k) Clearance of a Medical Device Sterilized Using a NO2 Process
Noxilizer, Inc. recently announced a 510(k) clearance from the US FDA for a medical device terminally sterilized using Noxilizer’s nitrogen dioxide sterilization process. "Receiving a…
Oncternal Therapeutics Merges With Tokalas to Form Clinical-Stage Biotechnology Company
Oncternal Therapeutics, Inc. and Tokalas, Inc., recently announced the two companies have completed a merger to create a new world-class clinical-stage oncology company with two…
PhRMA Release: Decade of Breakthroughs In Cancer
The pace of science is yielding remarkable innovation for cancer patients as we learn more about the underlying factors driving the spread and growth of…
